PDCD1 and neoplasm: We found that despite monotherapy of PD-1 blockade or RocA treatment suppressed tumor growth in a certain extent, the combination therapy of RocA and anti-PD-1 antibody exhibited the most potent suppressive effect on tumor growth (Fig. 2A-C).